Physician profile
Anne E Archbald
NPI 1942277553
$1,186.69
in general payments reported to CMS, 2019-2025
21 companies · $23.75 in 2025
The $23.75 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $891 · 2022: $87.44 · 2023: $171 · 2024: $14.20 · 2025: $23.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $208.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $177.83 | 2021-2025 | Evenity |
| Astrazeneca Pharmaceuticals LP | $127.74 | 2021-2023 | Farxiga |
| Janssen Pharmaceuticals, INC | $100.20 | 2021-2022 | |
| Lilly USA, LLC | $97.99 | 2021 | |
| Abbvie INC. | $96.08 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $77.88 | 2021 | |
| Radius Health, INC. | $69.29 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $68.45 | 2021 | |
| Novo Nordisk INC | $61.97 | 2021-2023 | Wegovy |
| Merck Sharp & Dohme LLC | $57.32 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $56.79 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $29.95 | 2021 | |
| Eisai INC. | $29.79 | 2021 | |
| Pfizer INC. | $24.83 | 2022 | |
| Jazz Pharmaceuticals INC. | $20.00 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $19.78 | 2021 | |
| Idorsia Pharmaceuticals US INC | $16.49 | 2023 | Quviviq |
| Glaxosmithkline, LLC. | $14.20 | 2024 | Shingrix, Arexvy |
| Sanofi-Aventis U.S. LLC | $13.88 | 2021 | |
| Impel Pharmaceuticals INC. | $13.48 | 2023 | Trudhesa |
| Takeda Pharmaceuticals U.S.A., INC. | $12.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Archbald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.